While manufacturers of FDA-approved injectable pentobarbital are warning states not to use the sedative in executions, some ...

Fallout from the Trump administration's aggressive global tariff regime continues to hit global markets and frustrate ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.

Trump's sweeping new tariffs, on top of previous levies and retaliation worldwide, are expected to increases prices for ...

This investment is pending the closing of the merger between SRx Health Solutions and Better Choice Company, which is scheduled for late-April. Upon closing, the combined companies will emerge as a ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

On Wednesday, two pharmacy benefit managers filed a motion to recuse U.S. District Judge Dan Polster after he failed to order ...

The providers say vision benefit managers now control 70% of the market, the plans disagree, and both sides want to win over ...

The death toll in Myanmar has surpassed 3,000, with more than 4,500 people injured, according to state television MRTV. Yet ...

As alternative PBM models seek to up-end a payer’s longstanding relationship with a large PBM, they must be prepared to ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target ...

Virginia lawmakers addressed scores of legislative vetoes and amendments from Republican Gov. Glenn Youngkin on Wednesday.